Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Medical Informatics|February 12, 2023
Acceptability and applicability of biometric iris scanning for the identification and follow up of highly mobile research participants living in fishing communities along the shores of Lake Victoria in Kenya, Tanzania, and UgandaElialilia Okello, Philip Ayieko, Zachary Kwena, et al.
Health Research Policy and Systems|August 7, 2019
Experiences of capacity strengthening in sanitation and hygiene research in Africa and Asia: the SHARE Research ConsortiumBelen Torondel, Emily Balls, Caroline Cleopatra Chisenga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2015
Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant CouplesAmalia S Magaret, Andrew Mujugira, James P Hughes, et al.
Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.
PLOS Global Public Health|October 18, 2023
Effect and cost-effectiveness of human-centred design-based approaches to increase adolescent uptake of modern contraceptives in Nigeria, Ethiopia and Tanzania: Population-based, quasi-experimental studiesCatarina Krug, Melissa Neuman, James E Rosen, et al.
JACC. Advances|January 16, 2025
Incidence and Progression of Diastolic Dysfunction in People With HIV in Tanzania: A Comparative CohortCody Cichowitz, Eva Mujuni, Godfrey A Kisigo, et al.
NPJ Vaccines|November 28, 2025
Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trialRebecca Wiggins, Kathy J Baisley, Jackton Indangasi, et al.
The Lancet. Global Health|February 16, 2024
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trialsKathy Baisley, Troy J Kemp, Nelly R Mugo, et al.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
Vaccine|June 30, 2026
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girlsHilary S Whitworth, Khalid B Beshir, Kathy J Baisley, et al.
Pageof 16